Literature DB >> 20124205

Younger children with MS have a distinct CSF inflammatory profile at disease onset.

D Chabas1, J Ness, A Belman, E A Yeh, N Kuntz, M P Gorman, J B Strober, I De Kouchkovsky, C McCulloch, T Chitnis, M Rodriguez, B Weinstock-Guttman, L B Krupp, E Waubant.   

Abstract

BACKGROUND: The clinical and MRI presentation differs between earlier- and later-onset pediatric multiple sclerosis (MS), whereas the effect of age on the CSF inflammatory profile is unknown and may contribute to delayed diagnosis.
OBJECTIVES: To compare the CSF cellular and immunoglobulin G (IgG) profiles between earlier- and later-onset pediatric MS.
METHODS: We queried the databases of 6 pediatric MS centers for earlier-onset (onset <11 years) and later-onset (> or = 11 and <18 years) patients with MS or clinically isolated syndrome who underwent CSF analysis within the first 3 months of presentation (observational study). We compared CSF white blood cell (WBC) differential count, IgG index, and IgG oligoclonal bands between age groups.
RESULTS: We identified 40 earlier-onset (mean age at onset = 7.2 +/- 2.7 years, 60% females) and 67 later-onset pediatric MS patients (15.1 +/- 1.7 years, 63% females). Although WBC count tended to be higher in earlier-onset patients (median = 9/mm(3) [0-343] vs 6 [0-140], p = 0.15), they had a lower proportion of lymphocytes (70% [0-100] vs 93% [0-100] of WBCs, p = 0.0085; difference = +3% per 1-year increase of age, p = 0.0011) and higher proportion of neutrophils than later-onset patients (0.5% [0-75] vs 0% [0-50] of WBCs, p = 0.16; difference = -1% per 1-year increase of age, p = 0.033). In earlier-onset disease, fewer patients had an elevated IgG index than in the later-onset group (35% vs 68% of patients, p = 0.031).
CONCLUSION: Age modifies the CSF profile at pediatric multiple sclerosis (MS) onset, which may mislead the diagnosis. Our findings suggest an activation of the innate rather than the adaptive immune system in the earlier stages of MS or an immature immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124205      PMCID: PMC2816008          DOI: 10.1212/WNL.0b013e3181ce5db0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Age of puberty: data from the United States of America.

Authors:  P A Lee; S S Guo; H E Kulin
Journal:  APMIS       Date:  2001-02       Impact factor: 3.205

2.  Prospective study of multiple sclerosis with early onset.

Authors:  A Ghezzi; C Pozzilli; M Liguori; M G Marrosu; N Milani; C Milanese; I Simone; M Zaffaroni
Journal:  Mult Scler       Date:  2002-04       Impact factor: 6.312

3.  Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Authors:  R C Dale; C de Sousa; W K Chong; T C Cox; B Harding; B G Neville
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

4.  Multiple sclerosis in children under 6 years of age.

Authors:  M Ruggieri; A Polizzi; L Pavone; L M Grimaldi
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

5.  Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.

Authors:  M Tintoré; A Rovira; L Brieva; E Grivé; R Jardí; C Borrás; X Montalban
Journal:  Mult Scler       Date:  2001-12       Impact factor: 6.312

6.  The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children.

Authors:  R Riikonen
Journal:  Acta Neurol Scand       Date:  1989-11       Impact factor: 3.209

7.  Interpretation of traumatic lumbar punctures: who can go home?

Authors:  Suzan S Mazor; Jennifer E McNulty; Genie E Roosevelt
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

8.  Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.

Authors:  Silvia Tenembaum; Nestor Chamoles; Natalio Fejerman
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

Review 9.  The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?

Authors:  Howard L Weiner
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

10.  Multiple sclerosis in childhood: report of 15 cases.

Authors:  F Hanefeld; H J Bauer; H J Christen; B Kruse; H Bruhn; J Frahm
Journal:  Brain Dev       Date:  1991-11       Impact factor: 1.961

View more
  27 in total

Review 1.  First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.

Authors:  Jessica Johnston; Tsz-Yin So
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

2.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

3.  Clinical and MRI phenotype of children with MOG antibodies.

Authors:  Cristina Fernandez-Carbonell; David Vargas-Lowy; Alexander Musallam; Brian Healy; Katherine McLaughlin; Kai W Wucherpfennig; Tanuja Chitnis
Journal:  Mult Scler       Date:  2015-06-03       Impact factor: 6.312

Review 4.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

Review 5.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

6.  Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.

Authors:  Maria A Rocca; Paola Valsasina; Martina Absinta; Lucia Moiola; Angelo Ghezzi; Pierangelo Veggiotti; Maria P Amato; Mark A Horsfield; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

Review 7.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 8.  Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis.

Authors:  Sithara Ramdas; Danny Morrison; Michael Absoud; Ming Lim
Journal:  BMJ Case Rep       Date:  2016-10-04

9.  Pediatric Inflammatory and Autoimmune Neurologic Disorders at a Tertiary Medical Center.

Authors:  Angela M Curcio; Jennifer M Bain; Erin S Beck; Wendy S Vargas
Journal:  J Child Neurol       Date:  2020-07-17       Impact factor: 1.987

10.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.